DeDora Capital
AZN icon

DeDora Capital’s AstraZeneca AZN Stock Holding History

DeDora Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$360K Buy
2,227
+1
+0% +$167 0.08% 92
2026
Q2 		$422K Sell
2,226
-7
-0.3% -$1.32K 0.09% 91
2026
Q1 		$440K Buy
2,233
+4
+0.2% +$771 0.11% 84
2025
Q4 		$410K Buy
2,229
+78
+4% +$13.7K 0.1% 89
2025
Q3 		$330K Hold
2,151
– – 0.08% 101
2025
Q2 		$301K Buy
2,151
+150
+7% +$21K 0.08% 102
2025
Q1 		$294K Buy
+2,001
New +$290K 0.08% 100
2022
Q2 		– Sell
-45
Closed -$6K – 126
2022
Q1 		$6K Buy
+45
New +$5.4K ﹤0.01% 333

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

DeDora Capital's AZN Position: Q3 2026 in Review

DeDora Capital increased its AstraZeneca (AZN) stake by 0.04% in Q3 2026, buying an estimated $167 and bringing the position to 2,227 shares worth $360K. The position accounts for 0.08% of the portfolio, ranked #92.

DeDora Capital first reported a position in AZN in Q1 2022 and has held it in 8 quarters since. The position peaked at $440K in Q1 2026. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • DeDora Capital held 2,227 shares of AstraZeneca worth $360K as of Q3 2026.
  • DeDora Capital bought 1 AstraZeneca share in Q3 2026, an estimated $167.
  • AstraZeneca made up 0.08% of DeDora Capital's portfolio in Q3 2026, its #92 holding.
  • DeDora Capital first reported a position in AstraZeneca in Q1 2022 and has held it in 8 quarters since.
  • DeDora Capital's AstraZeneca position peaked at $440K in Q1 2026.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.